Carcinogenicity of smokeless tobacco: Evidence from studies in humans & experimental animals
- PMID: 30778001
- PMCID: PMC6396560
- DOI: 10.4103/ijmr.IJMR_149_18
Carcinogenicity of smokeless tobacco: Evidence from studies in humans & experimental animals
Abstract
A Working Group of the Monographs programme of the International Agency for Research on Cancer has classified smokeless tobacco as carcinogenic to humans (Group 1). This review article summarizes the data that support the evaluations of sufficient evidence in humans and in experimental animals for the carcinogenicity of smokeless tobacco whether used alone or with betel quid. It also identifies compounds of smokeless tobacco relevant to carcinogenicity (prominently tobacco-specific nitrosamines) and addiction (nicotine). The epidemiological evidence is summarized for oral cancer, other cancers associated with smokeless tobacco and oral potentially malignant lesions with a focus on analytical studies from the SEARO Region. Studies on cancer in experimental animals are summarized with a focus on studies applying smokeless tobacco products typical for the regions, such as mishri and naswar.
Keywords: Cancer bioassays; carcinogenicity; oral cancer; smokeless tobacco; tobacco-specific carcinogens.
Conflict of interest statement
None
Similar articles
-
Epidemiology of cancer by tobacco products and the significance of TSNA.Crit Rev Toxicol. 1996;26(2):183-98. doi: 10.3109/10408449609017930. Crit Rev Toxicol. 1996. PMID: 8688160 Review.
-
Naswar (Smokeless Tobacco) Use and the Risk of Oral Cancer in Pakistan: A Systematic Review With Meta-Analysis.Nicotine Tob Res. 2019 Jan 1;21(1):32-40. doi: 10.1093/ntr/ntx281. Nicotine Tob Res. 2019. PMID: 29294113
-
Alert for an epidemic of oral cancer due to use of the betel quid substitutes gutkha and pan masala: a review of agents and causative mechanisms.Mutagenesis. 2004 Jul;19(4):251-62. doi: 10.1093/mutage/geh036. Mutagenesis. 2004. PMID: 15215323 Review.
-
Smokeless tobacco and cancer.Lancet Oncol. 2008 Jul;9(7):667-75. doi: 10.1016/S1470-2045(08)70173-6. Lancet Oncol. 2008. PMID: 18598931 Review.
-
Smokeless tobacco and oral cancer.J Mass Dent Soc. 2001 Spring;50(1):26-9, 47. J Mass Dent Soc. 2001. PMID: 11326709 Review. No abstract available.
Cited by
-
The Potential of Phytochemicals in Oral Cancer Prevention and Therapy: A Review of the Evidence.Biomolecules. 2020 Aug 6;10(8):1150. doi: 10.3390/biom10081150. Biomolecules. 2020. PMID: 32781654 Free PMC article. Review.
-
Impact of COVID-19 on the early detection of oral cancer: A special emphasis on high risk populations.Oral Oncol. 2020 Jul;106:104760. doi: 10.1016/j.oraloncology.2020.104760. Epub 2020 May 3. Oral Oncol. 2020. PMID: 32423663 Free PMC article. No abstract available.
-
Nicotine mediated epithelial modulations: An in-vitro evidence.J Oral Biol Craniofac Res. 2023 Nov-Dec;13(6):796-800. doi: 10.1016/j.jobcr.2023.11.001. Epub 2023 Dec 9. J Oral Biol Craniofac Res. 2023. PMID: 38111634 Free PMC article.
-
Genetic and epigenetic instability induced by betel quid associated chemicals.Toxicol Rep. 2023 Feb 4;10:223-234. doi: 10.1016/j.toxrep.2023.02.001. eCollection 2023. Toxicol Rep. 2023. PMID: 36845258 Free PMC article. Review.
-
Advantages of the Combinatorial Molecular Targeted Therapy of Head and Neck Cancer-A Step before Anakoinosis-Based Personalized Treatment.Cancers (Basel). 2023 Aug 24;15(17):4247. doi: 10.3390/cancers15174247. Cancers (Basel). 2023. PMID: 37686523 Free PMC article. Review.
References
-
- IARC monograph on the evaluation of carcinogenic risk of chemicals to humans. Tobacco habits other than smoking; betel quid and areca nut chewing and some related nitrosamines. Vol. 37. Lyon: IARC; 1985. International Agency for Research on Cancer. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical